• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: TOVX )

    3.220 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EDT, Sep 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 600
    Open 3.220
    Bid (Size) 3.150 (1)
    Ask (Size) 3.670 (1)
    Prev. Close 3.220
    Today's Range 3.220 - 3.220
    52wk Range 2.665 - 17.11
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga

    Performance

    YTD
    -70.79%
    -70.79%
    1 Month
    -37.69%
    -37.69%
    3 Month
    -51.85%
    -51.85%
    6 Month
    -72.00%
    -72.00%
    1 Year
    -75.23%
    -75.23%

    More News

    Read More
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    What's Going On With Theriva Biologics Stock?
    Via Benzinga
    Peering Into Theriva Biologics's Recent Short Interest
    Via Benzinga
    What's Going On With Theriva Biologics (TOVX) Stock?
    Via Benzinga
    Preview: Theriva Biologics's Earnings
    Via Benzinga
    Nasdaq Jumps Over 100 Points; Dell Posts Upbeat Results
    Via Benzinga
    Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma
    Via News Direct
    Exposures Product Safety
    Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
    Via Benzinga
    Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
    Via Benzinga
    Exposures Fossil Fuels
    Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    TOVX Stock Earnings: Theriva Biologics Beats EPS for Q2 2024
    Via InvestorPlace
    Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers
    Via News Direct
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
    Via News Direct
    Exposures Product Safety
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    TOVX Stock Earnings: Theriva Biologics Beats EPS for Q1 2024
    Via InvestorPlace
    Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers
    Via News Direct
    Earnings Scheduled For March 25, 2024
    Via Benzinga
    How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need
    Via News Direct
    Topics Death
    Exposures Death
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.